Stephan Fath
Stephan joined Roland Berger in 2015 where he specializes in advising global pharmaceutical, MedTech, and chemical industries, as well as private equity funds and investors.
Throughout his career, Stephan has developed multiple corporate strategies, including overseeing the successful creation of innovative supply models for specialty drugs. In addition, Stephan has extensive experience working on large-scale organizational transformative projects across the globe.
Stephan Fath has an interdisciplinary background, holding a double degree in Business Administration and Chemistry from the University of Duesseldorf, Germany.
Ensuring future drug availability
Podcast, March 12, 2025
Global MedTech: Balancing innovation and operational efficiency
STUDY, February 20, 2025
Operational excellence benchmarking: Shaping the future of MedTech
Article, November 13, 2024
Global Pharma Study 2024 – a new age of performance programs
Study, October 22, 2024
Why AI is a game changer for the pharmaceutical industry
Article, October 8, 2024
Designing your global manufacturing network
Article, March 15, 2024
Cutting the cost of gene therapy manufacturing
Article, July 6, 2023
M&A opportunities in biotechnology
Article, November 7, 2022
Mastering supply chain crises in the pharmaceutical industry
Article, July 11, 2022
Future of health 3 - How the phygital model is going to transform healthcare
Study, September 24, 2021